Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia
Clinical trial NCT00005609 · COMPLETED
Trial details
- NCT number
- NCT00005609
- Sponsor
- Eastern Cooperative Oncology Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-04-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.